Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCS + intranasal antihistamine vs INCS + oral antihistamine for moderate-to-severe allergic rhinitis
ChiCTR2500112481Phase 4Not yet recruiting
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in allergic rhinitis (AR) comparing INCS + oral antihistamine (Flixonase + Kezamin) with INCS + intranasal antihistamine (Dimens) (2 arms). Primary endpoints: Total Nasal Symptom Score (TNSS), Total Ocular Symptom Score (TOSS) and 2 more. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
fluticasone propionatemizolastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2500112481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112481.